22 November 2004 - 08:01, Stan Kaufman said
Permalink

CV Outcomes is pleased to provide licensing opportunities for the
Peripheral Artery Questionnaire. The PAQ is a disease-specific health status measure for patients with peripheral arterial disease. Like the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy
Questionnaire, the PAQ has been rigorously tested to demonstrate its
validity, reliability and responsiveness. For a disease such as
peripheral arterial disease, in which the primary goal of treatment is
to improve patients’ symptoms, function and quality of life, it is hoped
that the PAQ can serve as a primary endpoint in clinical trials, as a
marker of severely affected patients requiring treatment and as a tool
for improving the quality and follow-up of treated patients.

The PAQ was co-developed by Dr. John Spertus, Director of Outcomes
Research at the Mid America Heart Institute, and Dr. Krishna
Rocha-Singh, an interventional Cardiologist at the Prairie Heart
Institute in Springfield Illinois. Leveraging their combined extensive
methodological and clinical expertise, they were able to significantly
advance the quality of outcomes assessment in this growing population of patients. The PAQ is currently being used in several observational
registries and clinical trials.